Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Niceritrol

Copy Product Info
🥰Excellent
Catalog No. T19861Cas No. 5868-05-3
Alias Perycit, Cardiolipol, Bufor

Niceritrol (Cardiolipol) is a niacin ester that reduces cholesterol and triglycerides in total plasma and in the VLD and LD lipoprotein fractions.

Niceritrol

Niceritrol

Copy Product Info
🥰Excellent
Purity: 97.02%
Catalog No. T19861Alias Perycit, Cardiolipol, BuforCas No. 5868-05-3
Niceritrol (Cardiolipol) is a niacin ester that reduces cholesterol and triglycerides in total plasma and in the VLD and LD lipoprotein fractions.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$55In StockIn Stock
2 mg$77In StockIn Stock
5 mg$111In StockIn Stock
10 mg$158In StockIn Stock
25 mg$283In StockIn Stock
50 mg$426In StockIn Stock
100 mg$629In StockIn Stock
1 mL x 10 mM (in DMSO)$153In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:97.02%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Niceritrol AI Summary
Niceritrol exhibits moderate liver toxicity, evidenced by a 5.0% incidence rate during clinical trials and elevated serum activity levels of ALT, AST, or alkaline phosphatase. However, no acute liver toxicity, severe hepatitis, chronic liver disease, or other severe liver conditions were observed. This compound has demonstrated efficacy in inhibiting the entry of the Ebola virus with an AC50 value of 2238.7 nM observed in the green channel assay. Additionally, it showcases potential antiviral activity against SARS-CoV-2, displaying a 46.14% inhibition of virus-induced cytotoxicity in Caco-2 cells at 10 µM after 48 hours. It also inhibits the SARS-CoV-2 3CL-Pro protease by 8.673% at 20 µM and 0.44% inhibition of virus-induced cytotoxicity in VERO-6 cells at 10 µM after 48 hours. Furthermore, Niceritrol shows inhibition of human HDAC6 enzyme activity with 7.98% inhibition using a commercial peptide substrate..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Niceritrol (Cardiolipol) is a niacin ester that reduces cholesterol and triglycerides in total plasma and in the VLD and LD lipoprotein fractions.
SynonymsPerycit, Cardiolipol, Bufor
Chemical Properties
Molecular Weight556.52
FormulaC29H24N4O8
Cas No.5868-05-3
SmilesC(COC(=O)C=1C=CC=NC1)(COC(=O)C=2C=CC=NC2)(COC(=O)C=3C=CC=NC3)COC(=O)C=4C=CC=NC4
Relative Density.1.347g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year
Solubility Information
DMSO: 12 mg/mL (21.56 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.7969 mL8.9844 mL17.9688 mL89.8440 mL
5 mM0.3594 mL1.7969 mL3.5938 mL17.9688 mL
10 mM0.1797 mL0.8984 mL1.7969 mL8.9844 mL
20 mM0.0898 mL0.4492 mL0.8984 mL4.4922 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Niceritrol | purchase Niceritrol | Niceritrol cost | order Niceritrol | Niceritrol chemical structure | Niceritrol formula | Niceritrol molecular weight